| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $23K | — | -98.9% |
| Cost of Revenue | $24K | — | -98.7% |
| Gross Profit | -$790 | — | -100.2% |
| R&D Expense | $14K | — | +19.3% |
| SG&A Expense | $328K | — | -16.4% |
| Operating Income | -$540K | — | +12.6% |
| Pre-tax Income | -$544K | — | +12.8% |
| Income Tax | $0 | — | — |
| Net Income | -$544K | — | +12.8% |
| EPS (Diluted) | -$0.23 | — | -542.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $80K | -84.2% | — |
| Inventory | $667K | -1.4% | -43.4% |
| Current Assets | $5.2M | -4.6% | -20.6% |
| Total Assets | $9.0M | -2.3% | -4.6% |
| Current Liabilities | $796K | +52.9% | -49.0% |
| Total Liabilities | $947K | +48.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$148K | — | +82.1% |
| Capital Expenditures | $325 | — | -96.4% |
| Investing Cash Flow | -$14K | — | +10.6% |
| Financing Cash Flow | $60K | — | +7042.9% |
| Free Cash Flow | -$148K | — | +82.2% |
| -44.6% |
| Stockholders' Equity | $8.1M | -6.1% | +4.1% |